New pill HRS7415 tested in advanced cancer patients – early safety results
NCT ID NCT05318833
First seen Mar 14, 2026 · Last updated Jun 13, 2026 · Updated 13 times
Summary
This early-phase study tested an experimental cancer pill, HRS7415, in 38 adults with advanced solid tumors that had spread. The main goals were to check the drug's safety, find the best dose, and see how the body processes it. Researchers monitored side effects and tumor response, but this is a first step to see if the drug is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, 250021, China
Conditions
Explore the condition pages connected to this study.